Rossari Biotech Limited (NSE:ROSSARI)

Rossari Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	35,161	33,476	37,399	32,878	50,189	53,775
Market Cap Growth	-17.78%	-10.49%	13.75%	-34.49%	-6.67%	-
Enterprise Value	36,167	34,283	37,924	32,853	49,805	52,708
Last Close Price	635.05	604.19	676.07	594.90	909.24	1032.50
PE Ratio	26.04	24.55	28.62	30.65	51.39	67.04
Forward PE	20.71	21.24	24.16	21.14	32.93	-
PS Ratio	1.65	1.61	2.04	1.99	3.38	7.58
PB Ratio	2.97	2.82	3.57	3.59	6.23	13.16
P/TBV Ratio	3.74	3.56	4.76	5.13	9.22	13.60
P/FCF Ratio	-	-	-	27.70	-	-
P/OCF Ratio	-	24.36	86.46	21.69	170.96	112.58
PEG Ratio	1.15	1.81	1.81	1.81	1.81	-
EV/Sales Ratio	1.69	1.65	2.07	1.98	3.36	7.43
EV/EBITDA Ratio	14.09	13.79	15.68	15.37	28.17	42.87
EV/EBIT Ratio	19.13	18.31	20.76	21.67	38.54	52.58
EV/FCF Ratio	-	-	-	27.68	-	-
Debt / Equity Ratio	0.18	0.18	0.11	0.08	0.01	-
Debt / EBITDA Ratio	0.85	0.86	0.49	0.34	0.05	-
Debt / FCF Ratio	-	-	-	0.62	-	-
Asset Turnover	-	1.20	1.25	1.26	1.63	1.37
Inventory Turnover	-	4.52	5.53	6.22	7.80	6.05
Quick Ratio	-	1.10	1.17	1.45	1.25	1.55
Current Ratio	-	1.94	1.99	2.07	2.07	2.36
Return on Equity (ROE)	-	12.21%	13.32%	12.47%	16.10%	23.02%
Return on Assets (ROA)	-	6.75%	7.77%	7.22%	8.88%	12.13%
Return on Capital (ROIC)	9.13%	9.11%	10.60%	10.51%	13.21%	16.43%
Return on Capital Employed (ROCE)	-	13.80%	15.90%	14.90%	13.40%	24.40%
Earnings Yield	3.84%	4.07%	3.49%	3.26%	1.95%	1.49%
FCF Yield	-	-0.63%	-2.35%	3.61%	-0.18%	-0.19%
Dividend Yield	0.08%	0.08%	0.07%	0.08%	0.06%	0.05%
Payout Ratio	-	2.03%	2.11%	2.57%	2.82%	3.16%
Buyback Yield / Dilution	-0.07%	-0.08%	0.05%	-0.33%	-6.37%	-5.16%
Total Shareholder Return	0.01%	0.00%	0.13%	-0.24%	-6.31%	-5.12%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.